NasdaqCM - Delayed Quote • USD
Onconetix, Inc. (ONCO)
At close: May 28 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.2 | -0.18 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 1 | 1 |
| Avg. Estimate | 58k | -- | 58k | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | 58k |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 12/31/2022 | 3/31/2023 | 6/30/2023 | 9/30/2023 |
|---|---|---|---|---|
| EPS Est. | -0.26 | -0.21 | -0.15 | -0.19 |
| EPS Actual | -0.2 | -0.18 | -0.21 | -0.27 |
| Difference | 0.06 | 0.03 | -0.06 | -0.08 |
| Surprise % | 23.10% | 14.30% | -40.00% | -42.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -0.21 | 0 | -0.76 | -0.85 |
| 30 Days Ago | -0.21 | 0 | -0.76 | -0.85 |
| 60 Days Ago | -0.21 | 0 | -0.76 | -0.85 |
| 90 Days Ago | -0.21 | 0 | -0.76 | -0.85 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ONCO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 7.90% |
| Next Qtr. | -- | -- | -- | 10.20% |
| Current Year | -- | -- | -- | 4.80% |
| Next Year | -- | -- | -- | 12.50% |
| Next 5 Years (per annum) | -- | -- | -- | 11.27% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | Maxim Group: Buy to Hold | 9/13/2023 |
| Maintains | HC Wainwright & Co.: Buy | 4/26/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 2/1/2023 |
| Initiated | HC Wainwright & Co.: Buy | 12/9/2022 |
| Initiated | Maxim Group: Buy | 12/8/2022 |
Related Tickers
SCPX Scorpius Holdings, Inc.
0.1119
+6.37%
NBY NovaBay Pharmaceuticals, Inc.
0.1410
+6.98%
KTRA Kintara Therapeutics, Inc.
0.1879
+11.85%
MBIO Mustang Bio, Inc.
0.1885
-10.20%
TOVX Theriva Biologics, Inc.
0.2710
-11.44%
CYTO Altamira Therapeutics Ltd.
1.6100
-9.55%
ALLR Allarity Therapeutics, Inc.
0.5752
-0.10%
NLSP NLS Pharmaceutics Ltd.
0.1745
+2.05%
VIRI Virios Therapeutics, Inc.
0.2349
+12.18%
GRTX Galera Therapeutics, Inc.
0.2040
+4.08%